Search Results - "Lipold, Laura"

Is Pap testing still needed after hysterectomy? by Sobel, Halle G, Everett, Elise, Lipold, Laura D

Get full text

Gap in Sexual Dysfunction Management Between Male and Female Patients Seen in Primary Care: An Observational Study by Stanley, Elizabeth E, Pfoh, Elizabeth, Lipold, Laura, Martinez, Kathryn

“…Female sexual dysfunction (FSD), defined as clinically distressing problems with desire, arousal, orgasm, or pain, affects 12% of US women. Despite…”
Get full text

Change in individual physicians’ screening mammography completion rates following the updated USPSTF guideline supporting shared decision making: An observational cohort study by Martinez, Kathryn A., Deshpande, Abhishek, Lipold, Laura, Rothberg, Michael B.

“…•The strongest predictor of a physician’s post-2009 screening behavior was their pre-2009 screening behavior.•Physicians may not be practicing shared decision…”
Get full text

Best practice models for delivering women's health care by Batur, Pelin, Lipold, Laura

Get full text

Response to requests for contraception in one direct-to-consumer telemedicine service by Martinez, Kathryn A., Rastogi, Radhika, Lipold, Laura, Rothberg, Michael B.

“…To describe real-world care seeking and contraception provision in one direct to consumer telemedicine platform. We described encounters with reproductive age…”
Get full text

Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years by Jin, Xian Wen, Lipold, Laura, Foucher, Julie, Sikon, Andrea, Brainard, Jennifer, Belinson, Jerome, Schramm, Sarah, Nottingham, Kelly, Hu, Bo, Rothberg, Michael B.

“…Background Cervical cancer screening guidelines for women aged ≥30 years allow for co-testing or primary cytology testing. Our objective was to determine the…”
Get full text

Is there a time limit for systemic menopausal hormone therapy? by Lipold, Laura Dorr, Batur, Pelin, Kagan, Risa

“…In deciding whether it is time to stop hormone therapy, in addition to the patient's age we need to consider her preferences, symptoms, quality of life, time…”
Get full text

Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system by Linfield, Debra T., Rothberg, Michael B., Pfoh, Elizabeth R., Noss, Ryan, Cassard, Lydia, Powers, Joseph C., Lipold, Laura, Martinez, Kathryn A.

“…Purpose The United States Preventive Services Task Force recommends primary care physicians refer patients at high risk for BRCA1/2 mutations to genetic…”
Get full text

In Reply: Menopausal hormone therapy by Lipold, Laura Dorr, Batur, Pelin, Kagan, Risa

Get full text

A risk prediction model to allow personalized screening for cervical cancer by Rothberg, Michael B., Hu, Bo, Lipold, Laura, Schramm, Sarah, Jin, Xian Wen, Sikon, Andrea, Taksler, Glen B.

“…Importance Cervical cancer screening guidelines are in evolution. Current guidelines do not differentiate recommendations based on individual patient risk…”
Get full text

Cervical cancer screening: what's new and what's coming? by Jin, Xian Wen, Lipold, Laura, McKenzie, Margaret, Sikon, Andrea

“…In their 2012 guidelines for cervical cancer screening, several organizations call for less-frequent but more-effective screening that incorporates testing for…”
Get full text

Human papillomavirus vaccine: safe, effective, underused by Jin, Xian Wen, Lipold, Laura, Sikon, Andrea, Rome, Ellen

“…Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for females age 9 to 26 and for males age 11 to 26, yet vaccination…”
Get full text